MedTrace Logo

The Impact of Artichoke Leaf Extract on Blood Cholesterol: Primary Study

NCT02270164 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-05-19

No results posted yet for this study

Summary

Pycrinil® is a purified extract of the artichoke leaf. Artichoke leaf extract (ALE) has some clinical trial data suggesting benefit in the treatment of cholesterol disorders in several countries, but this effect has not been studied in a U.S. population. The investigators will give ALE or a placebo to overweight men and women with low "good" cholesterol to see if ALE increases their good cholesterol. The investigators will also make sure that ALE is safe.

Conditions

  • Lipid Metabolism Disorders

Interventions

DIETARY_SUPPLEMENT

Artichoke Leaf Extract

Capsule

OTHER

Placebo

Capsule

Sponsors & Collaborators

  • Indena S.p.A

    collaborator INDUSTRY

  • University of Mississippi Medical Center

    lead OTHER

Principal Investigators

  • Daniel M Riche, PharmD · University of Mississippi Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02270164 on ClinicalTrials.gov